NW
← Newsroom
SemiconductorNovember 16, 2026 · 2 min read

Forge Nano Reports Third Quarter 2026 Results and Reiterates Guidance

Forge Nano Holdings, Inc. (NASDAQ: NANO) reported its financial and operating results for the third quarter ended September 30, 2026, and reiterated its 2026 guidance. The company began trading on Nasdaq on October 22, 2026, under the ticker symbol "NANO", raising more than $130 million in gross proceeds in connection with its public listing.

The listing followed completion of a business combination with Archimedes Tech SPAC Partners II Co. The proceeds comprised $123 million of PIPE financing and approximately $8.4 million remaining in the SPAC trust account after redemptions, before transaction expenses and other closing payments.

For the nine months ended September 30, 2026, Forge Nano, Inc. reported $6,067 of GAAP revenue and $7,515 of government grants invoiced, in thousands, alongside $8,338 of pre-acquisition HZO revenue. Total amounts of revenue and grants invoiced were $21,920. For 2026, the company expects $18 million in revenue, $12.7 million of government grant income and $9.4 million of HZO revenue, assuming the acquisition had occurred on January 1, 2026.

On the equipment side, Forge Nano expanded manufacturing capacity for TEPHRA ALD systems by over 3x. In May it delivered a TEPHRA wafer-fab tool to a Fortune Global 500 communications company for commercial photonics, and in June it received a further order for integrated photonic-device manufacturing. Its high-aspect-ratio coatings were independently validated by C2MI at 1,000:1, defect-free.

On August 19, the company broke ground on America's Battery Gigafactory in Morrisville, North Carolina. The expansion will turn the existing 100,000-square-foot operation into a campus approaching 315,000 square feet, designed for approximately 3 GWh of annual lithium-ion cell capacity, and is expected to create more than 250 jobs. Production is planned to start in 2028.

Forge Nano completed its all-stock acquisition of HZO on November 4, 2026, with no cash consideration. In September it entered a joint development agreement with Nanexa to develop large-scale, GMP-compliant ALD manufacturing equipment for the PharmaShell platform. "After 15 years of pioneering next-generation ALD technology, Forge Nano is entering a defining new phase of commercial growth," said Paul Lichty, Co-Founder and Chief Executive Officer of Forge Nano.

Source: Forge Nano news

Forge Nano Reports Third Quarter 2026 Results and Reiterates Guidance | Nanotechnology World